Stock EUCI EUROCINE VACCINES AB
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Eurocine Vaccines AB

Equities

EUCI

SE0015382155

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
0.0446 SEK +10.95% Intraday chart for Eurocine Vaccines AB -3.46% -3.04%
Feb. 28 Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Feb. 15 Certain Shares of Eurocine Vaccines AB are subject to a Lock-Up Agreement Ending on 15-FEB-2024. CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Correction - Eurocine Vaccines discloses interim report for July - September 2023
AQ
Eurocine Vaccines discloses interim report for Juli - September 2023
AQ
Eurocine Vaccines discloses interim report for July 2022 - March 2023
AQ
Eurocine Vaccines discloses half-year report for July - December 2022
AQ
Eurocine Vaccines decides to develop mRNA-based vaccine candidate against chlamydia
AQ
Outstanding results for Eurocine Vaccines' mRNA based HSV-2 candidate
AQ
Eurocine Vaccines : Outstanding results for Eurocine Vaccines´ mRNA based HSV-2 candidate
PU
Eurocine Vaccines : acute; newly added HSV-2 vaccine candidate gains patent protection in South Korea
PU
Eurocine Vaccines discloses year-end report for the fiscal year 2021/2022
AQ
Disclosure notice in Eurocine Vaccines
AQ
Eurocine Vaccines : outlines a strategic development plan for its newly added therapeutic HSV-2 vaccine candidate
PU
Eurocine Vaccines expands its portfolio with a therapeutic HSV-2 vaccine candidate
AQ
Eurocine Vaccines publishes interim report for July 2021 - March 2022
AQ
Eurocine Vaccines : publishes CEO interview
PU
Eurocine Vaccines publishes half-year report for July - December 2021
AQ
Eurocine Vaccines enters into agreement with Flerie Invest to secure exercise of warrants of series TO 4
AQ
Eurocine Vaccines resolves on scientific advice with the Swedish Medical Products Agency ahead of clinical trial application
AQ
Eurocine Vaccines discloses interim report for July - September 2021
AQ
Eurocine Vaccines : Disclosure notice in Eurocine Vaccines
AQ
Eurocine Vaccines : discloses year-end report for the fiscal year 2020/2021
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EUCI Stock
  4. News Eurocine Vaccines AB
  5. Press Releases